# Gulf Resources, Inc.: financial statements, quarterly

GURE · Nasdaq · CIK 885462 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gure.md) · [Financials](/companies/gure/financials.md) · [Filings](/companies/gure/filings.md) · [Insiders](/companies/gure/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gure/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5.9](/filings/0001193805-24-001395.md) | [6.9 d](/filings/0001193805-26-001126.md) | [1.3](/filings/0001493152-26-045124.md) | [2.4](/filings/0001493152-26-045125.md) | [2.2](/filings/0001193805-25-001627.md) | [1.7 d](/filings/0001493152-26-044873.md) | [1.6](/filings/0001493152-26-045126.md) | [8.3](/filings/0001493152-26-045127.md) | [9.0](/filings/0001193805-25-001627.md) | [6.4 d](/filings/0001493152-26-044873.md) | [2.4](/filings/0001493152-26-045126.md) | [12.9](/filings/0001493152-26-045127.md) |
| Cost of revenue | $m | not reported | not reported | [2.1](/filings/0001193805-24-001240.md) | [5.1](/filings/0001193805-24-001241.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(2.3)](/filings/0001193805-24-001395.md) | [(7.9) d](/filings/0001193805-26-001126.md) | [(5.3)](/filings/0001493152-26-045124.md) | [(5.1)](/filings/0001493152-26-045125.md) | [(4.6)](/filings/0001193805-25-001627.md) | [(7.3) d](/filings/0001493152-26-044873.md) | [(4.7)](/filings/0001493152-26-045126.md) | [(0.8)](/filings/0001493152-26-045127.md) | [(0.3)](/filings/0001193805-25-001627.md) | [(2.9) d](/filings/0001493152-26-044873.md) | [(4.1)](/filings/0001493152-26-045126.md) | [1.3](/filings/0001493152-26-045127.md) |
| Interest expense | $m | [0.0](/filings/0001193805-24-001395.md) | [0.0 d](/filings/0001193805-26-001126.md) | [0.0](/filings/0001493152-26-045124.md) | [0.0](/filings/0001493152-26-045125.md) | [0.0](/filings/0001193805-25-001627.md) | [0.0 d](/filings/0001493152-26-044873.md) | [0.0](/filings/0001493152-26-045126.md) | [0.0](/filings/0001493152-26-045127.md) | [0.0](/filings/0001193805-25-001627.md) | [0.3 d](/filings/0001193805-26-001105.md) | [0.1](/filings/0001493152-26-045126.md) | [0.1](/filings/0001493152-26-045127.md) |
| Income tax | $m | [(0.5)](/filings/0001193805-24-001395.md) | [4.4 d](/filings/0001193805-26-001126.md) | [(1.3)](/filings/0001493152-26-045124.md) | [(1.2)](/filings/0001493152-26-045125.md) | [(1.1)](/filings/0001193805-25-001627.md) | [5.2 d](/filings/0001493152-26-044873.md) | [0.0](/filings/0001193805-25-000638.md) | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [(1.8)](/filings/0001193805-24-001395.md) | [(58.8) d](/filings/0001193805-26-001126.md) | [(4.0)](/filings/0001493152-26-045124.md) | [(33.1)](/filings/0001493152-26-045125.md) | [(3.5)](/filings/0001193805-25-001627.md) | [(19.3) d](/filings/0001493152-26-044873.md) | [(4.7)](/filings/0001493152-26-045126.md) | [(0.8)](/filings/0001493152-26-045127.md) | [(35.7)](/filings/0001193805-25-001627.md) | [(2.9) d](/filings/0001493152-26-044873.md) | [(3.9)](/filings/0001493152-26-045126.md) | [1.1](/filings/0001493152-26-045127.md) |
| Diluted EPS | $ per share | not reported | not reported | [(3.66)](/filings/0001493152-26-045124.md) | [(30.32)](/filings/0001493152-26-045125.md) | not reported | not reported | [(3.93)](/filings/0001493152-26-045126.md) | [(0.60)](/filings/0001493152-26-045127.md) | not reported | not reported | [(2.48)](/filings/0001493152-26-045126.md) | [0.64](/filings/0001493152-26-045127.md) |
| Basic EPS | $ per share | [(0.17)](/filings/0001193805-24-001395.md) | not reported | [(3.66)](/filings/0001493152-26-045124.md) | [(30.32)](/filings/0001493152-26-045125.md) | [(3.20)](/filings/0001193805-25-001627.md) | not reported | [(3.93)](/filings/0001493152-26-045126.md) | [(0.60)](/filings/0001493152-26-045127.md) | [(26.35)](/filings/0001193805-25-001627.md) | not reported | [(2.48)](/filings/0001493152-26-045126.md) | [0.64](/filings/0001493152-26-045127.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: not reported
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [104](/filings/0001193805-23-001515.md) | [72.2](/filings/0001193805-24-001395.md) | [70.8](/filings/0001193805-24-001240.md) | [10.4](/filings/0001193805-24-001241.md) | [11.2](/filings/0001193805-24-001395.md) | [10.1](/filings/0001493152-26-045125.md) | [8.5](/filings/0001493152-26-045124.md) | [7.7](/filings/0001493152-26-045125.md) | [5.8](/filings/0001193805-25-001627.md) | [0.0](/filings/0001493152-26-045127.md) | [6.5](/filings/0001493152-26-045126.md) | [9.2](/filings/0001493152-26-045127.md) |
| Current assets | $m | [115](/filings/0001193805-23-001515.md) | [86.1](/filings/0001193805-26-001126.md) | [85.1](/filings/0001193805-24-001240.md) | [20.8](/filings/0001193805-24-001241.md) | [21.3](/filings/0001193805-24-001395.md) | [17.5](/filings/0001493152-26-045125.md) | [17.6](/filings/0001493152-26-045124.md) | [20.3](/filings/0001493152-26-045125.md) | [15.7](/filings/0001193805-25-001627.md) | [24.6](/filings/0001493152-26-045127.md) | [25.6](/filings/0001493152-26-045126.md) | [31.0](/filings/0001493152-26-045127.md) |
| Total assets | $m | [279](/filings/0001193805-24-001395.md) | [227](/filings/0001193805-26-001126.md) | [222](/filings/0001493152-26-045124.md) | [194](/filings/0001493152-26-045125.md) | [194](/filings/0001193805-25-001627.md) | [168](/filings/0001493152-26-045125.md) | [164](/filings/0001493152-26-045126.md) | [163](/filings/0001493152-26-045127.md) | [132](/filings/0001193805-25-001627.md) | [134](/filings/0001493152-26-045127.md) | [133](/filings/0001493152-26-045126.md) | [137](/filings/0001493152-26-045127.md) |
| Current liabilities | $m | [9.9](/filings/0001193805-23-001515.md) | [12.6](/filings/0001193805-26-001126.md) | [12.3](/filings/0001193805-24-001240.md) | [19.0](/filings/0001193805-24-001241.md) | [19.2](/filings/0001193805-24-001395.md) | [13.0](/filings/0001493152-26-045125.md) | [10.5](/filings/0001493152-26-045124.md) | [10.0](/filings/0001493152-26-045125.md) | [17.1](/filings/0001193805-25-001627.md) | [8.2](/filings/0001493152-26-045127.md) | [10.9](/filings/0001493152-26-045126.md) | [11.7](/filings/0001493152-26-045127.md) |
| Total liabilities | $m | [18.2](/filings/0001193805-23-001515.md) | [21.4](/filings/0001193805-26-001126.md) | [21.0](/filings/0001193805-24-001240.md) | [27.0](/filings/0001193805-24-001241.md) | [27.4](/filings/0001193805-24-001395.md) | [25.0](/filings/0001493152-26-045125.md) | [22.4](/filings/0001493152-26-045124.md) | [21.7](/filings/0001493152-26-045125.md) | [24.4](/filings/0001193805-25-001627.md) | [22.3](/filings/0001493152-26-045127.md) | [22.8](/filings/0001493152-26-045126.md) | [23.4](/filings/0001493152-26-045127.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [2.8](/filings/0001493152-26-045127.md) | [5.3](/filings/0001493152-26-045126.md) | [5.4](/filings/0001493152-26-045127.md) |
| Shareholders' equity | $m | [261](/filings/0001193805-24-001395.md) | [205](/filings/0001493152-26-045125.md) | [201](/filings/0001493152-26-045125.md) | [167](/filings/0001493152-26-045125.md) | [167](/filings/0001193805-25-001627.md) | [143](/filings/0001493152-26-045127.md) | [142](/filings/0001493152-26-045127.md) | [141](/filings/0001493152-26-045127.md) | [107](/filings/0001193805-25-001627.md) | [111](/filings/0001493152-26-045127.md) | [110](/filings/0001493152-26-045127.md) | [113](/filings/0001493152-26-045127.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.1) d](/filings/0001193805-24-001395.md) | [(42.6) d](/filings/0001193805-26-001126.md) | [(1.3)](/filings/0001493152-26-045124.md) | [0.5 d](/filings/0001493152-26-045125.md) | [0.5 d](/filings/0001193805-25-001627.md) | [1.0 d](/filings/0001493152-26-044873.md) | [(1.6)](/filings/0001493152-26-045126.md) | [(0.6) d](/filings/0001493152-26-045127.md) | [6.7 d](/filings/0001193805-25-001627.md) | [3.2 d](/filings/0001493152-26-044873.md) | [1.1](/filings/0001493152-26-045126.md) | [(5.3) d](/filings/0001493152-26-045127.md) |
| Capital expenditure | $m | [15.1](/filings/0001193805-23-001515.md) | not reported | not reported | not reported | [31.6 d](/filings/0001193805-25-001627.md) | [(31.6) d](/filings/0001493152-26-044873.md) | not reported | not reported | not reported | [0.2 d](/filings/0001493152-26-044873.md) | [0.5](/filings/0001493152-26-045126.md) | [1.2 d](/filings/0001493152-26-045127.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2018 (2018-03-31) | Q2 FY2018 (2018-06-30) | Q3 FY2018 (2018-09-30) | Q1 FY2019 (2019-03-31) | Q2 FY2019 (2019-06-30) | Q1 FY2020 (2020-03-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [46.8](/filings/0001193805-19-000483.md) | [46.8](/filings/0001193805-19-000746.md) | [46.8](/filings/0001193805-18-001337.md) | [9.4](/filings/0001193805-20-000616.md) | [47.2](/filings/0001193805-19-000746.md) | [9.5](/filings/0001193805-20-000616.md) | [1.1](/filings/0001493152-26-045124.md) | [1.1](/filings/0001493152-26-045125.md) | [1.2](/filings/0001493152-26-045126.md) | [1.4](/filings/0001493152-26-045127.md) | [1.6](/filings/0001493152-26-045126.md) | [1.8](/filings/0001493152-26-045127.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,813,531 at 2026-09-29, from the cover of the [10-Q filed 2026-09-30](/filings/0001493152-26-045127.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.